Skye Bioscience Inc (SKYE)

[Monksdream]

This cannabis issue in the medical subsector hasn't taken off compared to a bout a dozen or so similar issues.

Meanwhile, sitting over investors' heads are warrants issued to Roth Capital, a firm noted for making lousy (for investors) deals to keep financially strapped biomedical companies alive. Roth was issued warrants to purchase 480,000 shares at 0.25 per share. At current pricing that's about a 45 percent discount.

Here comes the pump followed by the dump.